查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1586189

細胞健康篩檢市場：按測試類型、樣本類型分類 - 2025-2030 年全球預測

Cellular Health Screening Market by Test Type (Heavy Metal Tests, Inflammation Tests, Multi-Test Panels), Sample Type (Blood, Body Fluids) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

細胞健康篩檢市場2023年估值為31億美元，預計2024年將達34.7億美元，複合年成長率為11.75%，預計到2030年將達到67.7億美元。

細胞健康篩檢包括評估細胞生物標記物，以評估整體健康狀況和潛在疾病風險。這個領域由測量細胞老化、氧化壓力和粒線體健康的技術定義，對於預防性醫療保健和個人化醫療至關重要。細胞健康篩檢的需求源自於全球健康意識的提高以及慢性病管理中對早期檢測工具的需求。細胞健康篩檢的應用超越了臨床用途（包括健康中心和個人用途），可以為各種最終用戶（包括醫療保健提供者、研究人員和健身專業人員）提供服務。市場成長受到生物標記檢測技術進步和個人化醫療解決方案投資增加的顯著影響。隨著人口老化，對非侵入性診斷工具的需求顯著增加，為相關人員創造了利潤豐厚的機會。然而，高成本、監管複雜、測試結果缺乏標準化等挑戰正在限制市場。儘管存在這些障礙，但持續的創新（例如整合人工智慧以獲得準確結果以及開發攜帶式且經濟高效的設備）提供了有希望的成長軌跡。公司可以利用這些機會，專注於遵守不斷變化的監管標準，同時投資研發以提高測試準確性並降低成本。擴大教育和宣傳工作以提高消費者對細胞健康篩檢益處的認知也至關重要。市場的本質是動態的，其特點是技術快速進步和消費者對個人化健康解決方案的需求不斷成長。基因組學和奈米技術等領域的創新有可能進一步改變這一領域，並促進早期疾病檢測和健康監測的進步。追求長期成長的公司應優先考慮適應這些技術趨勢並培養策略夥伴關係關係，以擴大市場覆蓋範圍和競爭力。透過克服現有挑戰並擁抱創新，公司可以顯著影響細胞健康篩檢、推動市場擴張並改善人類健康結果。

主要市場統計
基準年[2023] 31億美元
預測年份 [2024] 34.7億美元
預測年份 [2030] 67.7億美元
複合年成長率（%） 11.75%

市場動態：快速發展的細胞健康篩檢市場的關鍵市場洞察

供需的動態交互作用正在改變細胞健康篩檢市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 乳癌和攝護腺癌篩檢可以顯著降低個人的死亡風險。
    • 慢性病造成的經濟負擔日益加重
    • 更多採用端粒功能程序
  • 市場限制因素
    • 過度診斷是篩檢中不可避免的一部分，會對人們造成有害後果，例如心理困擾和失禁。
  • 市場機會
    • 活性化研究活動並快速採用直接接觸客戶的方法
    • 政府對預防性醫療保健的興趣日益濃厚
  • 市場挑戰
    • 一些經濟體檢費用上升和資源短缺

波特五力：駕馭細胞健康篩檢市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解細胞健康篩檢市場的外部影響

外部宏觀環境因素在塑造細胞健康篩檢市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解細胞健康篩檢市場的競爭格局

細胞健康篩檢市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣細胞健康篩檢市場供應商的績效評估

FPNV定位矩陣是評估細胞健康篩檢市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製細胞健康篩檢市場的成就之路

對於旨在加強在全球市場的影響力的公司來說，細胞健康篩檢市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 乳癌和攝護腺癌篩檢可以顯著降低個人的死亡風險。
      • 慢性病造成的經濟負擔增加
      • 更多採用端粒性能計劃
    • 抑制因素
      • 過度診斷是篩檢的必要條件，會對人們造成有害後果，例如心理困擾和失禁。
    • 機會
      • 研究活動迅速增加並採用直接面對客戶的方法
      • 政府對預防性醫療保健的興趣日益濃厚
    • 任務
      • 一些經濟體測試成本高且資源稀缺
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章按測試類型分類的細胞健康篩檢市場

  • 重金屬測試
  • 發炎測試
  • 多測試板
  • 氧化壓力測試
  • 端粒測試

第7章依樣本類型分類的細胞健康篩檢市場

  • 血
  • 體液

第8章美洲細胞健康篩檢市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太細胞健康篩檢市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲細胞健康篩檢市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Cell Science Systems Corporation
  • Cell Signaling Technology, Inc.
  • Danaher Corp
  • Laboratory Corporation of America Holdings
  • Life Length SL
  • LifeVault Bio, Inc
  • Merck KGaA
  • OPKO Health, Inc.
  • PerkinElmer Inc.
  • Quest Diagnostics
  • Repeat Diagnostics, Inc.
  • SpectraCell Laboratories Inc
  • Thermo Fisher Scientific Inc.
  • Viome Life Sciences, Inc.
Product Code: MRR-433AB1DC28DE

The Cellular Health Screening Market was valued at USD 3.10 billion in 2023, expected to reach USD 3.47 billion in 2024, and is projected to grow at a CAGR of 11.75%, to USD 6.77 billion by 2030.

Cellular health screening encompasses the evaluation of cellular biomarkers to assess overall health status and potential disease risks. This field is defined by techniques measuring cellular aging, oxidative stress, and mitochondrial health, crucial for preventive healthcare and personalized medicine. The necessity of cellular health screening arises from the increasing global health awareness and demand for early detection tools in chronic disease management. Its applications extend beyond clinical settings, including wellness centers and individual use, serving diverse end-users like healthcare providers, researchers, and fitness professionals. The market growth is significantly influenced by technological advancements in biomarker detection and increasing investment in personalized healthcare solutions. As the aging population grows, there's a substantial rise in demand for non-invasive diagnostic tools, presenting lucrative opportunities for stakeholders. However, challenges such as high costs, regulatory complexities, and a lack of standardization in test results pose significant market restraints. Despite these hurdles, ongoing innovations like artificial intelligence integration for precise results and developing portable, cost-effective devices offer promising growth trajectories. Companies can capitalize on these opportunities by investing in research and development to improve test accuracy and reduce costs, while also focusing on compliance with evolving regulatory standards. Expanding educational outreach to increase consumer awareness about the benefits of cellular health screening is also crucial. The market's nature is dynamic, characterized by rapid technological progress and increasing consumer demand for personalized health solutions. Innovation in areas like genomics and nanotechnology could further revolutionize this field, facilitating advancements in early disease detection and health monitoring. Companies aiming for long-term growth should prioritize adapting to these technological trends and fostering strategic partnerships to enhance market reach and competitiveness. By navigating existing challenges and embracing innovation, businesses can significantly impact cellular health screening, driving market expansion and improving population health outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 3.10 billion
Estimated Year [2024] USD 3.47 billion
Forecast Year [2030] USD 6.77 billion
CAGR (%) 11.75%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cellular Health Screening Market

The Cellular Health Screening Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Screening for breast and prostate cancer can significantly reduce an individual's risk of dying
    • Increasing economic burden of chronic diseases
    • Increasing adoption of telomere performance programs
  • Market Restraints
    • Overdiagnosis is inevitability of screening leading to harmful consequences for people, including psychological distress, and incontinence
  • Market Opportunities
    • Rise in research activities, and a rapidly growing adoption of direct to customer approach
    • Rising government focus towards preventive healthcare
  • Market Challenges
    • High costs of screening and lack of resources in some economies

Porter's Five Forces: A Strategic Tool for Navigating the Cellular Health Screening Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cellular Health Screening Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cellular Health Screening Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cellular Health Screening Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cellular Health Screening Market

A detailed market share analysis in the Cellular Health Screening Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cellular Health Screening Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cellular Health Screening Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cellular Health Screening Market

A strategic analysis of the Cellular Health Screening Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cellular Health Screening Market, highlighting leading vendors and their innovative profiles. These include Cell Science Systems Corporation, Cell Signaling Technology, Inc., Danaher Corp, Laboratory Corporation of America Holdings, Life Length S.L., LifeVault Bio, Inc, Merck KGaA, OPKO Health, Inc., PerkinElmer Inc., Quest Diagnostics, Repeat Diagnostics, Inc., SpectraCell Laboratories Inc, Thermo Fisher Scientific Inc., and Viome Life Sciences, Inc..

Market Segmentation & Coverage

This research report categorizes the Cellular Health Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test Type, market is studied across Heavy Metal Tests, Inflammation Tests, Multi-Test Panels, Oxidative Stress Tests, and Telomere Tests.
  • Based on Sample Type, market is studied across Blood and Body Fluids.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Screening for breast and prostate cancer can significantly reduce an individual's risk of dying
      • 5.1.1.2. Increasing economic burden of chronic diseases
      • 5.1.1.3. Increasing adoption of telomere performance programs
    • 5.1.2. Restraints
      • 5.1.2.1. Overdiagnosis is inevitability of screening leading to harmful consequences for people, including psychological distress, and incontinence
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in research activities, and a rapidly growing adoption of direct to customer approach
      • 5.1.3.2. Rising government focus towards preventive healthcare
    • 5.1.4. Challenges
      • 5.1.4.1. High costs of screening and lack of resources in some economies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cellular Health Screening Market, by Test Type

  • 6.1. Introduction
  • 6.2. Heavy Metal Tests
  • 6.3. Inflammation Tests
  • 6.4. Multi-Test Panels
  • 6.5. Oxidative Stress Tests
  • 6.6. Telomere Tests

7. Cellular Health Screening Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Blood
  • 7.3. Body Fluids

8. Americas Cellular Health Screening Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cellular Health Screening Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cellular Health Screening Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Cell Science Systems Corporation
  • 2. Cell Signaling Technology, Inc.
  • 3. Danaher Corp
  • 4. Laboratory Corporation of America Holdings
  • 5. Life Length S.L.
  • 6. LifeVault Bio, Inc
  • 7. Merck KGaA
  • 8. OPKO Health, Inc.
  • 9. PerkinElmer Inc.
  • 10. Quest Diagnostics
  • 11. Repeat Diagnostics, Inc.
  • 12. SpectraCell Laboratories Inc
  • 13. Thermo Fisher Scientific Inc.
  • 14. Viome Life Sciences, Inc.

LIST OF FIGURES

  • FIGURE 1. CELLULAR HEALTH SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. CELLULAR HEALTH SCREENING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CELLULAR HEALTH SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CELLULAR HEALTH SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CELLULAR HEALTH SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CELLULAR HEALTH SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELLULAR HEALTH SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELLULAR HEALTH SCREENING MARKET DYNAMICS
  • TABLE 7. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY HEAVY METAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY INFLAMMATION TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY MULTI-TEST PANELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY OXIDATIVE STRESS TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY TELOMERE TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELLULAR HEALTH SCREENING MARKET SIZE, BY BODY FLUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES CELLULAR HEALTH SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA CELLULAR HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM CELLULAR HEALTH SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. CELLULAR HEALTH SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. CELLULAR HEALTH SCREENING MARKET, FPNV POSITIONING MATRIX, 2023